Tag: FDA

StaffApril 18, 2023
daily-hit.jpg

4min00
The Daily Hit is a recap of the top financial news stories for April 18, 2023. On the Site House Committee Launches Probe into FDA’s Inaction on CBD Regulation Despite the legalization of cannabis containing less than 0.3% THC by the 2018 farm bill, the FDA has yet to issue regulations for CBD products. For […]

StaffJanuary 26, 2023
daily-hit.jpg

4min00
The Daily Hit is a recap of the top financial news stories for January 26, 2023. On the Site Curaleaf Closes Book on Legacy West Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is exiting a trio of legacy western states in search for better profits. The exodus will begin this month with the “proactive closure […]

StaffJanuary 24, 2023
daily-hit.jpg

4min00
The Daily Hit is a recap of the top financial news stories for January 24, 2023. On the Site FDA Releases Cannabis Industry Research Guidance The guidance document from the U.S. Food and Drug Administration follows the 2018 federal legalization of hemp via that year’s federal farm bill, which removed cannabis with less than 0.3% […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.